J&J vaccine deal to boost Aspen's global profile

The deal with Johnson & Johnson will also be a boost for exports and create an inflow of foreign currency

08 November 2020 - 00:00 By JANE STEINACKER

The Covid-19 vaccine deal Aspen has secured with Johnson & Johnson may not yield new direct jobs but will position SA as a major player in the international pharmaceutical industry and provide Aspen with a higher international profile to secure further deals.

“SA is not known to be a pharmaceutical destination. It is expected from Europe and Asia,” Stavros Nicolaou, group senior executive for strategic trade at Aspen Pharma Group, said this week...

This article is reserved for Sunday Times subscribers.

A subscription gives you full digital access to all Sunday Times content.

Already subscribed? Simply sign in below.

Registered on the BusinessLIVE, Business Day or Financial Mail websites? Sign in with the same details.



Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.